Cancer Clinical Trial
Official title:
An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States
Verified date | May 13, 2013 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- State-of-the art care for children with cancer or rare diseases is not available in all
countries. Owing to the proximity of Latin America and the growing numbers of Latinos already
in the United States, many international patients receiving specialized medical care in U.S.
hospitals are from Spanish-speaking countries. Although there are benefits associated with
obtaining specialized care in the United States, linguistic barriers and cultural differences
as well as the general stresses of caring for a child with a serious illness may affect
families ability to obtain adequate care for their children. Researchers are interested in
exploring the experiences and needs of international Latino families receiving medical care
for their child in the United States in order to help health care centers provide more
appropriate resources and improve the overall quality of culturally sensitive care.
Objectives:
- To understand the experiences of international Latino families who are receiving treatment
for their child or have enrolled their child in a research study in the United States.
Eligibility:
- Caregivers of a child between birth and 25 years of ages who are from Latin America
(which includes Mexico, all countries in Central America and South America, and
Spanish-speaking Caribbean countries) and who have traveled to the United States to
enroll their child in a research protocol and/or seek treatment for their child s
medical condition.
- Caregivers must have a child enrolled on a research protocol at the time of this study.
- Caregivers must have been away from their country of origin for a minimum of 3 months.
Design:
- This study requires a single interview that should take approximately 1 hour.
- Participants will complete the interview with a member of the research team who is
bilingual or fluent in Spanish.
- Participants will be asked open-ended questions about why they chose to come to the
United States, how they are adjusting to living and getting medical care for their child
in the United States, and what hopes they have for treatment outcomes and future medical
care.
- Researchers will record the interviews to be reviewed later. The recordings will be used
for this study only.
Status | Completed |
Enrollment | 22 |
Est. completion date | May 13, 2013 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
- INCLUSION CRITERIA: - Caregivers of children aged 0-25. - The children of the participants must be involved in clinical research or be receiving treatment for their child s medical condition. This includes but is not limited to oncological and hematological diseases, conditions requiring transplant, and rare immunodeficiency or genetic conditions. - The family traveled to the US for the purpose of addressing their child s medical condition. - Caregivers must be from a country outside of the United States. Care givers must be fluent in Spanish or English. - Caregiver has been away from the country of origin for a minimum of three months. - The child s treatment protocol PI must agree to have the research team contact potential participants in order to explore their interest in this protocol. EXCLUSION CRITERIA: - The caregiver participant immigrated to the US for reasons other than enrolling in a research study or addressing their child s medical condition. - Presence of psychotic symptoms or severe psychological distress, which in the judgment of the Principal or Associate Investigator or consulting psychiatrist would compromise the caregiver s ability to engage in the interview or is likely to interfere with the study procedures or results. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Mental Health (NIMH) |
United States,
Abbe M, Simon C, Angiolillo A, Ruccione K, Kodish ED. A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents. Pediatr Blood Cancer. 2006 Nov;47(6):819-24. — View Citation
Alegría M, Canino G, Ríos R, Vera M, Calderón J, Rusch D, Ortega AN. Inequalities in use of specialty mental health services among Latinos, African Americans, and non-Latino whites. Psychiatr Serv. 2002 Dec;53(12):1547-55. — View Citation
Barakat LP, Kazak AE, Meadows AT, Casey R, Meeske K, Stuber ML. Families surviving childhood cancer: a comparison of posttraumatic stress symptoms with families of healthy children. J Pediatr Psychol. 1997 Dec;22(6):843-59. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|